Machine Learning Prediction of 1-Year Refractive Error After SMILE (SMILE)

March 12, 2026 updated by: yuhao shao, Tongji University

Development and Internal Validation of a Multi-output Machine Learning Model for Predicting 1-Year Postoperative Refractive Prediction Error After Small Incision Lenticule Extraction and Comparative Virtual Planning Analysis Against ZEISS 4.0

This retrospective single-center observational study is designed to develop and internally validate a multi-output machine learning model for predicting 1-year postoperative refractive prediction error after small incision lenticule extraction (SMILE). The primary modeling target is 1-year spherical equivalent prediction error. Secondary targets include J0 prediction error, J45 prediction error, and postoperative uncorrected distance visual acuity in logarithm of the minimum angle of resolution. A secondary objective is to use the prediction framework to derive individualized nomogram recommendations and to compare these recommendations with ZEISS 4.0 planning in a virtual treatment-planning analysis.

Study Overview

Study Type

Observational

Enrollment (Actual)

1100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Shanghai Municipality
      • Shanghai, Shanghai Municipality, China, 200072
        • Shanghai Tenth People's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

People with moderate myopia who have undergone SMILE surgeries

Description

Inclusion Criteria:

  • Eyes that underwent SMILE for correction of myopia or myopic astigmatism
  • Availability of preoperative examination data and surgical planning data
  • Availability of postoperative follow-up data at approximately 1 year
  • Age ≥ 18 years

Exclusion Criteria:

  • Previous ocular surgery in the study eye
  • Ocular comorbidity likely to affect refractive or visual outcome
  • Intraoperative or postoperative complications that precluded standard outcome assessment
  • Missing key variables required for analysis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Training Cohort
Eyes included in the prespecified training dataset for development of the multi-output machine learning model.
Test Cohort
Eyes included in the prespecified independent test dataset for internal validation of the multi-output machine learning model.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean Absolute Error of Predicted 1-Year Postoperative Spherical Equivalent Prediction Error
Time Frame: 1 year after SMILE
Model performance for prediction of 1-year postoperative spherical equivalent prediction error, assessed in diopters.
1 year after SMILE

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean Absolute Error of Predicted 1-Year Postoperative J0 Prediction Error
Time Frame: 1 year after SMILE
Model performance for prediction of the cardinal astigmatic vector component (J0), assessed in diopters.
1 year after SMILE
Mean Absolute Error of Predicted 1-Year Postoperative J45 Prediction Error
Time Frame: 1 year after SMILE
Mean Absolute Error of Predicted 1-Year Postoperative J45 Prediction Error
1 year after SMILE

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2018

Primary Completion (Actual)

December 31, 2025

Study Completion (Actual)

January 31, 2026

Study Registration Dates

First Submitted

March 12, 2026

First Submitted That Met QC Criteria

March 12, 2026

First Posted (Actual)

March 17, 2026

Study Record Updates

Last Update Posted (Actual)

March 17, 2026

Last Update Submitted That Met QC Criteria

March 12, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2026ML
  • SHDC12025144 (Other Grant/Funding Number: Shanghai Hospital Development Center Foundation)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myopia

Subscribe